• Application Note

Lansoprazole: Isocratic Separation and Degradation by 0.4 N HCl

Lansoprazole: Isocratic Separation and Degradation by 0.4 N HCl

  • Waters Corporation
Acid reflux and GERD

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

This application brief highlights the isocratic separation and degradation of lansoprazole.

Introduction

Lansoprazole is used to treat ulcers, gastroesophageal reflux disease (GERD), and conditions where the stomach produces too much acid.

Experimental

Conditions

Column:

SunFire C18 4.6 x 150 mm, 5.0 μm (p/n: 186002559)

Mobile phase A:

20 mM HCOO-NH4 +, pH 3.0

Mobile phase B:

Acetonitrile

Isocratic:

as indicated

Flow rate:

1.4 mL/min

Injection volume:

2 μL

Sample Diluent:

75:25 H2O:ACN

Sample concentration:

350 μg/mL

Temperature:

30 °C

Detection:

UV @ 254 nm

Sampling rate:

10 pts/sec

Time Constant:

0.1

Instrument:

Waters Alliance HT 2795, with 2996

Conditions

Column:

SunFire C18 4.6 x 150 mm, 5.0 μm (p/n: 186002559)

SunFire C8 4.6 x 150 mm, 5.0 μm (p/n: 186002737)

Mobile phase A:

20 mM HCOO-NH4 +, pH 3.0

Mobile phase B:

Acetonitrile

Isocratic:

as indicated

Flow rate:

1.4 mL/min

Injection volume:

5 μL

Sample Diluent:

50:50 H2O:ACN

Sample concentration:

2.63 mg/mL

Temperature:

30 °C

Detection:

UV @ 254 nm

Sampling rate:

5 pts/sec

Time Constant:

1

Instrument:

Waters Alliance HT 2795, with 2996

Degradation Conditions:

Temperature: ambient

50 mg of Lansoprazole + 5 mL of 0.4N HCl stirred for ~ 30 seconds

Stop reaction by add 0.9 mL of 0.4N NaOH, then dilute with 1.9 mL ACN 

Lansoprazole degraded ~ 32%

Results and Discussion

Featured Products

WA41893, March 2005

Back To Top Back To Top